Board of Directors
Board of Directors
Christopher Locher, PhD
Dr. Locher is the CEO and Co-Founder and has over 20 years of biopharmaceutical industry experience developing new vaccines and therapeutics for multiple diseases. Prior to Versatope, he was a Senior Director at Vertex Pharmaceuticals in Boston where he held leadership and management roles in large infectious disease R&D programs and international collaborations.
Jim Kuo, MD, MBA
Dr. Kuo has over 25 years of experience in senior leadership roles in pharmaceutical business development. He has played key roles in leading venture capital financing, strategic partnerships, licensing and strategic planning in the genomics, small molecule, biotherapy, monoclonal antibody and inflammatory disease. He is currently the Chairman of the Board of Immunoprecise Antibodies and Monarch Labs.
Matt DeLisa, PhD
Dr. DeLisa is a Co-Founder of and the William L. Lewis Professor of Engineering at Cornell University. His research team focuses on the molecular machines of protein biosynthesis both as a toolbox for the discovery, design and manufacturing of biopharmaceuticals and as targets for reprogramming cellular physiology.
Dave Putnam, PhD
Dr. Putnam is also a Co-Founder of Versatope Therapeutics and Professor of Bioengineering at Cornell University. He has worked in the field of drug delivery and formulation of biomaterials for over 20 years. He and his collaborators have pioneered the development of probiotic exosomes and generated the strong preliminary data to support our preclinical development.